Refining the role of de novo protein-truncating variants in neurodevelopmental disorders by using population reference samples.
Ontology highlight
ABSTRACT: Recent research has uncovered an important role for de novo variation in neurodevelopmental disorders. Using aggregated data from 9,246 families with autism spectrum disorder, intellectual disability, or developmental delay, we found that ∼1/3 of de novo variants are independently present as standing variation in the Exome Aggregation Consortium's cohort of 60,706 adults, and these de novo variants do not contribute to neurodevelopmental risk. We further used a loss-of-function (LoF)-intolerance metric, pLI, to identify a subset of LoF-intolerant genes containing the observed signal of associated de novo protein-truncating variants (PTVs) in neurodevelopmental disorders. LoF-intolerant genes also carry a modest excess of inherited PTVs, although the strongest de novo-affected genes contrib
SUBMITTER: Kosmicki JA
PROVIDER: S-EPMC5496244 | biostudies-literature | 2017 Apr
REPOSITORIES: biostudies-literature
ACCESS DATA